● 新华社宁波11月2日电（记者段菁菁） 何立峰表示，中方愿与俄方一道，以两国元首重要共识为根本遵循，继续发挥总理定期会晤委员会机制 作用，深入推进双边各领域互利合作，反对单边主义和贸易保护主义，共同维护多边贸易体制。 切尔内申科表示，俄中关系正处于历史最好水平，各领域务实合作成果丰硕。俄方愿与中方一道，提升 合作水平，拓展合作领域，挖掘合作潜力，为俄中新时代全面战略协作伙伴关系注入新的动力。 双方有关部门围绕相关领域合作开展深入沟通交流，达成一系列合作成果和共识。 11月2日，国务院副总理、中俄总理定期会晤委员会中方主席何立峰同俄罗斯副总理、委员会俄方主席 切尔内申科在浙江省宁波市共同主持召开中俄总理定期会晤委员会第二十九次会议。 何立峰指出，今年以来，习近平主席与普京总统多次会晤，就深化中俄战略协作和各领域务实合作达成 新的重要共识，引领中俄关系行稳致远。在两国元首亲自关注和推动下，中俄务实领域合作机制持续完 善、交往更加密切，双边经贸合作保持平稳发展，重点项目扎实推进，相关领域合作有序开展、富有成 效。 ...

Company Overview - Performance Food Group (PFGC) shares increased by 3.8% to $108.72 in the last trading session, with a higher-than-average trading volume [1] - The stock has gained 5.5% over the past four weeks, indicating positive momentum [1] Strategic Developments - There is growing optimism regarding a potential strategic collaboration between Performance Food and US Foods, as both companies have begun an information-sharing process to explore regulatory considerations and synergies [2] Financial Performance Expectations - Performance Food is expected to report quarterly earnings of $1.16 per share, unchanged from the same quarter last year, with revenues projected at $16.86 billion, reflecting a 9.4% increase year-over-year [3] - The consensus EPS estimate for the quarter has been revised 1.6% higher in the last 30 days, suggesting a positive trend that may lead to price appreciation [4] Industry Context - Performance Food is part of the Zacks Food - Natural Foods Products industry, where another company, Sprouts Farmers (SFM), experienced a 1.7% decline in its last trading session and has returned -14.8% over the past month [4] - Sprouts Farmers' consensus EPS estimate has increased by 0.4% to $1.16, representing a 27.5% change compared to the previous year [5]

Core Insights - Inogen, Inc. reported an adjusted loss per share of 11 cents for Q1 2025, an improvement from a loss of 45 cents in the same period last year and better than the Zacks Consensus Estimate of a loss of 52 cents [1] - The company achieved revenues of $82.3 million for Q1 2025, reflecting a year-over-year increase of 5.5% and surpassing the Zacks Consensus Estimate by 3.3% [2] Revenue Performance - The revenue growth was primarily driven by increased demand and new customer acquisitions in domestic and international business-to-business channels, although this was partially offset by declines in direct-to-consumer sales and rental revenues [3] - Rental revenues decreased by 7.5% year-over-year to $13.8 million, while sales revenues increased by 8.5% to $68.5 million [4] Regional and Segment Analysis - Domestic business-to-business sales rose by 29.9% year-over-year to $21.5 million, driven by new customer demand [5] - International business-to-business sales increased by 22.9% year-over-year to $31.9 million, with a 27.9% increase at constant exchange rates [5] - Domestic direct-to-consumer sales fell by 26.8% year-over-year to $15 million [6] Profitability and Expenses - Adjusted gross profit increased by 4.9% year-over-year to $39.4 million, but the adjusted gross margin contracted by 20 basis points to 47.9% [7] - Sales and marketing expenses decreased by 11.8% to $23.8 million, R&D expenses fell by 38.7% to $4 million, and general and administrative expenses decreased by 5.2% to $16.2 million [8] Financial Position - Inogen ended Q1 2025 with cash and cash equivalents of $118.9 million, up from $113.8 million at the end of 2024 [9] - The company had no debt on its balance sheet, but net cash used in operating activities increased to $16.8 million from $4.7 million a year ago [10] Future Guidance - For Q2 2025, Inogen expects revenues between $89 million and $91 million, reflecting flat to 3% growth from Q2 2024 [11] - For the full year 2025, the revenue outlook is set at $352 million to $355 million, indicating a growth of 5-6% from 2024 [12] Strategic Developments - Inogen finalized a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., aimed at expanding its product portfolio and enhancing its innovation pipeline [14]